How to Determine Hepatitis Activity Using Tests and Symptoms?

Chronic hepatitis is a insidious disease that can progress unnoticed for years. However, to assess the prognosis and choose the correct therapy, it is critically important to determine the hepatitis activity—that is, the intensity of the inflammatory process in the liver tissue. The degree of activity determines how quickly organ damage progresses and the risk of developing fibrosis or cirrhosis.

Patients often confuse the mere presence of a virus (such as Hepatitis B or C) with active liver destruction. To take timely measures, it is necessary to understand how this process is assessed. In this practical guide, we will detail:

• Which blood biochemistry indicators (ALT, AST, bilirubin) point to inflammation;
• How minimal, moderate, and high hepatitis activity manifests in terms of symptoms;
• What the Knodell histological activity index (HAI) is;
• What modern non-invasive methods (elastography, predictive tests) can replace biopsy.

This knowledge will help you better understand your treating physician, monitor test results, and not miss dangerous changes in your body.

Step 1. Laboratory Diagnostics: Which Blood Tests to Order First?

The first and most accessible step in assessing liver health is a blood laboratory test. It is the biochemical indicators that allow the doctor to 'look inside' the organ without invasive procedures and determine how actively the inflammatory process is destroying liver cells (hepatocytes).

The basic screening is based on analyzing specific enzymes that signal tissue damage, as well as examining pigment and protein metabolism. These markers collectively help not only confirm the presence of inflammation but also assess the overall functional capacity of the liver at the current moment.

Assessing ALT and AST Enzymes and Their Norms in Chronic Hepatitis

Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are intracellular enzymes that enter the bloodstream when liver cells (hepatocytes) are damaged. Their level in blood biochemistry determines the degree of chronic hepatitis activity.

Normal values are:

• ALT: up to 31 U/L for women and up to 41 U/L for men.
• AST: up to 31 U/L for women and up to 37–40 U/L for men.

In chronic hepatitis, inflammation activity is assessed by the multiple of the upper limit of normal (ULN) exceeded:

• Minimal activity: exceeding the norm up to 3 times.
• Moderate activity: exceeding the norm 3–10 times.
• High activity: exceeding the norm more than 10 times.

The De Ritis ratio (AST/ALT ratio) is also important. In viral hepatitis, ALT usually exceeds AST, so the ratio drops below 1. If AST begins to predominate, it may indicate severe liver damage or progressive liver fibrosis.

Additional Biochemical Markers (Bilirubin, Total Protein, Alkaline Phosphatase)

In addition to transaminases, the following blood biochemistry indicators are critically important for assessing liver function and the severity of hepatitis:

• Bilirubin (total and direct). An increase in its level indicates impaired excretory function of the liver or bile stasis (cholestasis). With high hepatitis activity, an increase in the direct fraction is often observed.
• Alkaline Phosphatase (ALP). This enzyme is a primary marker of bile duct damage. Its significant increase (especially in combination with GGT—gamma-glutamyltransferase) indicates a cholestatic component of the inflammation.
• Total protein and albumin. The liver synthesizes vital blood proteins. A decrease in albumin level is an alarming sign, indicating suppression of the organ's synthetic function, which often occurs as the disease progresses and hepatitis transitions into cirrhosis.

Analyzing these markers in conjunction with ALT and AST allows the doctor not only to confirm inflammation but also to determine its nature (cytolytic or cholestatic) and assess the liver's reserve capacity.

Step 2. Symptom Assessment: How Does Different Degrees of Hepatitis Activity Manifest?

Laboratory tests provide an accurate picture of what is happening at the cellular level, but the human body responds to liver inflammation not only by changes in biochemical indicators. Clinical symptoms are an external reflection of how aggressively chronic hepatitis is progressing at the moment. The degree of inflammatory activity directly determines the patient's well-being: from a complete absence of complaints to severe intoxication.

Understanding these manifestations helps to suspect a deterioration of the condition in time and adjust therapy. Symptoms can range from barely noticeable weakness to classic signs indicating a serious threat to liver health. Let's examine exactly how our body signals different intensities of inflammation.

Signs of Minimal and Low Activity (Subclinical Course)

With minimal and low chronic hepatitis activity (corresponding to 1–3 points on the Knodell scale), the disease most often progresses silently—subclinically. Patients may not suspect the inflammatory process for years, attributing mild discomfort to stress and overexertion.

The main manifestations of this stage are non-specific:

• Increased fatigue: weakness occurs even after full rest or with usual exertion.
• Right upper quadrant discomfort: periodic feeling of heaviness or bloating, especially after fatty food or physical activity.
• Emotional lability: unexplained irritability, mild sleep disturbances (difficulty falling asleep, daytime drowsiness).
• Decreased appetite: occasional mild nausea.

Since the liver tissue itself lacks pain receptors (only its capsule can hurt when stretched), there are no obvious symptoms with mild inflammation. This is why a subclinical course requires regular laboratory monitoring, because even without complaints, liver cell destruction can continue slowly.

Symptoms of Moderate and High Activity (Asthenia, Jaundice, Skin Itching)

When the inflammatory process transitions to a moderate or high activity phase, the silent course is replaced by a pronounced clinical picture. The body can no longer compensate for liver cell damage, which manifests as a characteristic triad of symptoms:

• Severe asthenia. This is not just tiredness, but deep exhaustion that does not pass after sleep. Patients experience constant helplessness and apathy.
• Jaundice (icterus). Due to excess bilirubin, the sclera of the eyes and skin turn yellow. Urine takes on a dark color, while stool, conversely, becomes light.
• Skin itching. A tormenting symptom caused by the irritation of nerve endings by bile acids. It often worsens at night and interferes with sleep.

Heaviness in the right upper quadrant and nausea may also occur. These signs signal the need for urgent assessment of the organ's condition.

Step 3. The Gold Standard of Diagnosis: Determining Activity Using the Knodell Index (HAI)

Although blood biochemical tests and clinical symptoms provide the doctor with important clues, they only reflect the external picture of what is happening. To look into the core of the pathological process and accurately assess the degree of cell damage, morphological tissue examination is used in clinical practice. It is histological analysis that allows for the objective measurement of the level of inflammation and destruction in the liver.

The main tool for such an assessment is the histological activity index (HAI), most often calculated using the classical Knodell scale. This method is recognized as the "gold standard" of diagnosis because it translates visual changes in the tissues into precise numerical indicators, eliminating subjective guesswork and helping to formulate the most effective treatment plan.

What is HAI and how to interpret the Knodell scale scores

The Knodell Histological Activity Index (HAI) is a globally recognized semi-quantitative system used by pathologists to assess a liver biopsy. This indicator allows for the objective determination of the degree of inflammatory process activity and the severity of organ damage, which is extremely important when a patient is diagnosed with chronic hepatitis.

The calculation of HAI according to Knodell is based on summing scores from four key morphological components:

1. Periportal and/or bridging hepatocyte necrosis (0–10 points).
2. Degeneration and focal necrosis within lobules (0–4 points).
3. Inflammatory infiltrate in portal tracts (0–4 points).
4. Liver fibrosis (0–4 points).

The first three parameters determine the immediate degree of activity (inflammation intensity), while the fourth component reflects the stage of the disease (tissue structural changes).

The interpretation of the total score of the first three components is as follows:

• 0 points — inflammatory process is absent;
• 1–3 points — minimal hepatitis activity;
• 4–8 points — mild (low) activity;
• 9–12 points — moderate activity;
• 13–18 points — severe (high) activity.

The results obtained help the treating physician assess the prognosis of the disease and decide on the need for immediate antiviral therapy.

How a liver biopsy is performed and when it is necessary

To calculate the Knodell index, the doctor needs a microscopic fragment of the organ tissue. This is obtained using a percutaneous liver biopsy.

Procedure:

• Preparation and anesthesia. The patient lies on their back or left side. The doctor performs local anesthesia on the skin and underlying tissues in the intercostal area.
• Sample collection. Under ultrasound guidance, the specialist inserts a thin hollow needle that collects a column of liver tissue in a fraction of a second. The patient only feels brief pressure.
• Observation. After the procedure, the patient must stay in the hospital for several hours under medical supervision, lying on their right side with a hot water bottle/ice pack.

When is a biopsy truly necessary:

• Conflicting results. When data from non-invasive tests do not match the clinical picture and blood biochemistry indicators.
• Mixed pathology. When there is suspicion of a combination of viral hepatitis with autoimmune damage or fatty liver disease.
• Complex clinical cases. For an accurate assessment of the degree of inflammation activity and the stage of liver fibrosis before deciding on expensive or severe therapy.

Step 4. Modern non-invasive alternatives to liver biopsy

Although percutaneous biopsy was the only reliable way to look "inside" the pathological process for a long time, medicine is constantly advancing. Today, patients with chronic hepatitis are less often required to undergo this invasive and psychologically challenging procedure. Modern non-invasive methods allow for a highly accurate assessment of the degree of damage and density of liver tissue, avoiding the risks associated with puncturing the abdominal wall and possible complications.

These technologies are divided into two main groups: instrumental organ scanning and calculated laboratory indices. They are not only comfortable and safe for the patient but are also ideal for regular monitoring of disease dynamics, which is critically important for controlling inflammation activity and assessing the effectiveness of the therapy being administered.

Liver Elastography (FibroScan) for tissue density assessment

Elastography (or FibroScan) is an advanced ultrasound method that allows for non-contact and painless determination of liver tissue density (stiffness). The device emits low-frequency vibrations: the more pronounced the liver fibrosis, the faster the elastic wave passes through the organ.

The test result is measured in kilopascals (kPa) and correlated with the METAVIR scale:

• F0 (up to 5.8 kPa) — healthy state, no fibrosis;
• F1–F2 (5.9–9.5 kPa) — initial and moderate changes;
• F3 (9.6–12.5 kPa) — severe fibrosis;
• F4 (over 12.5 kPa) — liver cirrhosis.

The main advantage of FibroScan is its safety and the ability to be repeated multiple times to assess treatment dynamics. The procedure takes only 10–15 minutes, does not require hospitalization, and allows the doctor to promptly adjust therapy in chronic hepatitis. However, it should be remembered that severe inflammation (high ALT and AST activity) can falsely elevate density readings, so elastography should always be evaluated in conjunction with blood biochemistry.

Calculated serum tests (FibroTest, APRI) as a method for assessing fibrosis and inflammation

In addition to instrumental elastography, modern medicine offers highly accurate calculated methods based on blood biochemistry. These allow for the assessment of both liver fibrosis and the degree of necroinflammatory process activity.

• FibroTest and ActiTest. This is a patented test system that assesses a combination of key serum markers (including GGT, bilirubin, alpha-2-macroglobulin, apolipoprotein A1, and haptoglobin). ActiTest directly reflects viral activity and the severity of inflammation in liver tissue, serving as a non-invasive analog to histological examination.
• APRI Index (AST to Platelet Ratio Index). A simple and accessible calculated marker recommended by the WHO. Its calculation uses standard AST activity and platelet count from a complete blood count. The formula allows for the quick suspicion of advanced fibrosis or cirrhosis without additional costs.

Such calculated panels are indispensable for monitoring the condition of patients diagnosed with chronic hepatitis. They are completely safe, have no contraindications, and can be performed regularly to monitor the effectiveness of the therapy being administered.

Step 5. Step-by-step algorithm for monitoring hepatitis activity for the patient

Understanding medical indicators and test results is only half the battle. The main task for a patient with chronic hepatitis is to turn this knowledge into a clear, daily monitoring system. Systematic monitoring allows not only for tracking changes in the liver but also for warning of exacerbations, timely therapy adjustment, and maintaining a high quality of life.

To avoid being overwhelmed by the abundance of tests and doctor visits, it is necessary to establish a simple and understandable action algorithm. This will help you keep the disease under control, properly allocate resources for diagnostics, and know exactly when the situation requires scheduled monitoring versus immediate medical intervention.

Regularity of Examinations and Keeping a Medical Diary

Systematic control is the foundation of successful management of chronic hepatitis. To notice a change in the inflammatory process activity in time, it is necessary to strictly adhere to the examination schedule and record any changes in health status.

Recommended Examination Schedule (with stable progression):

• Every 3–6 months: Blood biochemistry test (assessment of ALT and AST activity, bilirubin level, alkaline phosphatase). This is a basic marker for controlling the degree of inflammation.
• Every 6–12 months: Abdominal ultrasound to assess the size and structure of the liver, as well as the condition of the bile ducts.
• Every 12 months: Elastography (FibroScan) to monitor the stage of liver fibrosis and a quantitative PCR test to control viral load.

Keeping a Medical Diary

The self-monitoring diary helps the treating physician see an objective picture of the disease in dynamics. It is recommended to record the following data:

Control Parameter	What exactly to record?	Recording Frequency
General well-being	Level of fatigue (on a scale of 1 to 10), sleep quality, appetite.	Daily
Specific symptoms	Presence of pain in the right upper quadrant, nausea, skin itching, or changes in urine color.	Upon appearance
Medication intake	Names of drugs, dosages, time of intake, and possible side effects.	Daily
Test results	Dynamics of ALT, AST, bilirubin, and platelet levels.	After each test

This structured approach allows for the timely detection of the disease transitioning from a phase of minimal activity to a more aggressive form.

Red Flags: When to Contact Your Doctor Urgently

Even with strict adherence to the examination schedule and keeping a medical diary, the liver condition can deteriorate suddenly. It is important for a patient with chronic hepatitis to know how to recognize critical signs from the body—the "red flags." Their appearance indicates a sharp activation of the inflammatory process or the development of dangerous complications requiring immediate medical attention.

Contact a doctor or call emergency services immediately if you notice the following symptoms:

• Rapidly worsening jaundice. Pronounced yellowing of the sclera of the eyes and skin, accompanied by darkening of urine to the color of dark beer and lightening of stool.
• Signs of hepatic encephalopathy. Sudden daytime drowsiness and nighttime insomnia, sluggishness, confusion, difficulty concentrating or with fine motor skills (e.g., change in handwriting).
• Edema syndrome. Rapid increase in abdominal volume (ascites) and the appearance of severe swelling in the legs.
• Bleeding and hematomas. Appearance of unexplained bruises on the body, bleeding gums, nosebleeds, as well as vomiting with blood or black, tarry stools.
• Intolerable skin itching. Tormenting itching that worsens at night and causes sleep deprivation.
• Fever and severe pain. Sharp pain in the right upper quadrant accompanied by a high body temperature without signs of a cold.

Ignoring these signs is life-threatening. If they occur, you cannot wait for a scheduled visit to a hepatologist or the results of another test—action must be taken immediately.

Conclusion

Determining the activity of chronic hepatitis is not a one-time test, but a comprehensive and continuous process of monitoring liver health. Timely assessment of ALT and AST enzyme levels, tracking clinical symptoms, and using modern non-invasive methods (such as elastography and calculated serum tests) allow for the early detection of inflammatory process activation and the prevention of fibrosis.

Understanding exactly how the disease progresses—whether it is minimal activity or pronounced inflammation according to the Knodell scale—gives the doctor the opportunity to select the most effective antiviral or hepatoprotective therapy. Remember that modern medicine can successfully control Hepatitis B and D, and Hepatitis C is completely curable in most cases.

Regular monitoring, keeping a medical diary, maintaining a diet, and abstaining from alcohol are your reliable foundation for preserving liver health and a long, fulfilling life. Do not postpone your visit to a hepatologist and keep your indicators under control.